Récepteur des folates et cancers épithéliaux de l`ovaire

!"#$%&$'()*$+),-./&$+)$&)#/0#$(+)
"%1&2".1/'3)*$).’-4/1($)
5("*"(1#)6$..$)
789:);7<%1&/'3)8014$(+1&/1($+)*$).’9+&):/(1+1$0=)
6$(41#$)*’>0#-.-?1$)@"*1#/.$)
7<%1&/.)A$0-0B)C:D7:B):/(1+)
!"'01-0)EFG>HC)IJ)0-4$KL($)IMNI)

!<.$+)*$+)5-./&$+)$0)#/0#"(-.-?1$))
! "#$%&'()*+,-.*+%/*+0)-123.*+,/+40-.*5/04+,/+1-063./+&#$304-.4/*+,-.*+%-+
*7.489*/+,/+%’:;<+/4+*-+0)$%&1-23.=+%-+,&>&*&3.+1/%%(%-&0/=+%-+103&**-.1/+/4+%-+
*(0>&/+$-021(%&90/#/.4+,/*+1/%%(%/*+/.+,&>&*&3.+0-$&,/+
! "#$%&'()*+,-.*+%-+0/#)487%-23.+,/+%’83#317*4)&./+/.+#/48&3.&./+%-'(/%%/+
/*4+&#$304-.4/+$3(0+%-+6&3*7.489*/+,/+%-+?@-,/.3*7%+#/48&3.&./+>)0&4-6%/+
A+0->&4-&%%/(0+B+,/+C03($/#/.4*+#)487%/*+$3(0+%-+#)487%-23.+,/+%’:;<=+:D<=+
$034)&./+/4+$83*$83%&$&,/*+
! DE%/+$034/14/(0+,(+1-.1/0F+
! DE%/+,’-11)%)0-23.+,(+,)>/%3$$/#/.4+4(#30-%F+
! :(C#/.4-23.+,/+%-+103&**-.1/+4(#30-%/+/4+-11(#(%-23.+,/+53%-4/*+,-.*+%-+
1/%%(%/+1-.1)0/(*/+->/1+(./+5304/+/G$0/**&3.+,(+0)1/$4/(0+-%$8-+*(CC90/.4+
%’&.4)0H4+,’(./+-$$0318/+48)0-$/(2'(/+

I0-.*$304/(0+,/*+53%-4/*+0),(&4*+JDKLM+@+
K-1&%&4/+%-+,&N(*&3.+
:O.&4)+5-&6%/+P+8-(4/+1-$-1&4)+
I0-.*$304/(0+,/*+53%-4/*+
13($%)*+-(G+$0343.*+
D)1/$4/(0+,/*+53%-4/*+JKD@-M+
@ +-C0)C)+*(0+%-+*(05-1/+
@ +&.4/0.-%&*-23.+
Q-(4/+-O.&4)+P+5-&6%/+1-$-1&4)+
RS(G+$-0+TDU+
:1&,/+53%&'(/+
LVWXYXY+
U)#)40/G/,+
U)#)40/G/,+
I)40-87,0353%-4/*+
T)48340/G-4/+
D-%240/G/,+
U)#)40/G/,+
:?LZ+[\Y\+@+; -$09*+L-%>/04+Q+/4+-%]=+R,(1-23.-%+?/**&3.+
A(/0+%-(&)K$KL(/0/1($)*$+),-./&$+)
43

!"#$%&$'()*$+)5-./&$+O)E"0"(/.1&"+)
! )P1?/0*^+-1&,/+53%&'(/+J>&4-#&./+V_M+
! !"#$%&$'()*'),-./&$+JKDM+3(+KVU+J53%-4/+6&.,&.C+$034/&.M+
! U034)&./+,/+W_`;+->/1+(.+%&/.+,’-.10-C/+JaU"M+*3(*+W+&*3530#/*+b=+
c+/4+d+J0-0/M+
! :O.&4)+KDb+e+Y\@Y\+TJ\]Y.TM+f+KDc+e+Y\+P_+T+JY+.TM+
! !<.$)%2Q+1-.-?1R'$^+13..(+$-0+/G/#$%/+$3(0+%/+0/&.+3(+1/0>/-(Y@[+
! A1++')0-(K/.^+%31-%&*)+g+%-+*(05-1/+-$&1-%/+$3%-0&*)/+,/*+1/%%(%/*W+J.3.+
/G$3*)+-(+13(0-.4+1&01(%-43&0/M+
! 6'($3%(1K")%/()%.'+1$'(+)#/0#$(+)"%1&2".1/'3+#-&*+*3.+0E%/+/*4+$/(+
1%-&0=+#-&*+%/+$%(*+*3(>/.4+/G$3*)+g+%-+1&01(%-23.+*-.C(&./h+
!"#$%&'#()*+,-.)#()/)01)2)34567&()8-(()34567&(/)9::;)
9<#1-$)=#-.,)-.)#(/)0%')>?@A)>-(7')*-'/)9::;)
BCD-7.1#$)">,)-.)#(/)8#$E-?)*-6/)!FF9)
;G($#H#4)I,)-.)#(/)0%')>?@A)>-(7')*-')9::;)

!"#$%&$'()*$+)5-./&$+O).-#/.1+/S-0)
! A1++'+)0-(K/'3)
! +KDb++J$%-1/.4-=+0/&.=+>/**&/=+$%/G(*+18303&,/*=+iLD=+C%-.,/*+*-%&>-&0/*+3(*+#-G&%%-&0/=+
13%3.=+$3(#3.=+%-&4+#-4/0./%%/M+KDc++J$%-1/.4-=+0-4/=+487#(*=+U<<M+/4+KDd+JTZM+
! A1++'+)K/.10+O),-(&$)$3%($++1-0)
! KDb+J1-01&.3#/+)$&,/0#3&,/+.-*3$8-07.C&/.=+1-.1/0*+3>-0&/.+.3.+#(1&./(G=+
1-01&.3#/+,(+13%+/4+(4)0(*=+1-.1/0+,(+0/&.+$0&#&25=+#)4-*4-*/*+,/*+1-01&.3#/*+
$-.10)-2'(/*Mj+KDc+J%/(1)#&/*+/4+%7#$83#/*Mj+KDd+J%/(1)#&/*M++
! 5!T)+-.'L.$NDIDJ+J$83*$83%&$-*/*+L+/4+;+-63.,-.4/*+,-.*+%/+*-.C+'(&+1%&>/.4+
*$)1&k'(/#/.4+%/*+$034)&./*+aU"M]+?-+%&6)0-23.+$3(00-&4+&.4/0>/.&0+,-.*+%/+13.40E%/+,/+
%’/G$0/**&3.+,(+KDb+g+%-+*(05-1/+,/*+1/%%(%/*+/4+H40/+(.+#-0'(/(0+*)0&'(/+,/*+4(#/(0*+g+
5304/+/G$0/**&3.+,(+KDb+13.40-&0/#/.4+-(G+&.,&>&,(*+*-&.*+3(+*3.+4-(G+$%-*#-2'(/+/*4+
5-&6%/+
! I-(G+,/+KD+*3%(6%/+&.4-14/+&,/.2'(/+'(/+%/+*4-,/+*3&4+$0)131/+3(+->-.1)+18/l+%/*+
$-2/.4/*+-m/&.4/*+,’(.+1-.1/0+,/+%’3>-&0/h+
!8#1JK-(()L,)-.)#(/)8#$E-?)*-6)!FF9M)
)9=?&N$)>,)-.)#(/)2)01)"&E)O-J4?&()!FF9M)
)BP?#$)P,)-.)#(/)8#$E-?)*-6)9::QM))
;=#6#()G,)-.)#(/)3R&")&$-)9::F)